<?xml version="1.0"?><?xml-stylesheet type="text/xsl" href="../../web/xslt/drug-table.xslt"?><drug name = "aztreonam inj VIAL>
<dose><value>500</value>
<value>1</value>
<value>2</value>
<value>90 - 120</value>
<value>150 - 200</value>
<value>60</value>
<value>90</value>
<value>120</value>
<value>75</value>
</dose><route><value>IM</value>
<value>IV</value>
<value>NEB</value>
</route><form><value>inj VIAL</value>
</form><drug><value>aztreonam inj VIAL</value>
</drug><strength><value>1 g</value>
<value>75 mg</value>
</strength><frequency><value>Q8H</value>
<value>Q12H</value>
<value>Q6H</value>
<value>TID</value>
</frequency><instruction><value></value>
</instruction><volume><value></value>
</volume><units><value>mg</value>
<value>g</value>
<value>mg/kg/day</value>
</units><additionalnotes><value>UTI. Total daily dose of 2 to 3 grams. If Creatinine Clearnace is 10 to 30 mL/minute: 50% of usual dose at usual interval. If Creatinine Clearance is less than 10 mL/minute: 25% of usual dose at usual interval.</value>
<value>Lower Respiratory Tract infection.. Total daily dose of 2 to 6 grams. If Creatinine Clearnace is 10 to 30 mL/minute: 50% of usual dose at usual interval. If Creatinine Clearance is less than 10 mL/minute: 25% of usual dose at usual interval.</value>
<value>Systemic infection. MAXIMUM dose: 8 g/day. If Creatinine Clearnace is 10 to 30 mL/minute: 50% of usual dose at usual interval. If Creatinine Clearance is less than 10 mL/minute: 25% of usual dose at usual interval.</value>
<value>MAXIMUM dose: 8 g/day. If Creatinine Clearnace is 10 to 30 mL/minute: 50% of usual dose at usual interval. If Creatinine Clearance is less than 10 mL/minute: 25% of usual dose at usual interval.</value>
<value>Cystic Fibrosis. MAXIMUM dose: 8 g/day or 200 mg/kg/day, whichever is less. If Creatinine Clearnace is 10 to 30 mL/minute: 50% of usual dose at usual interval. If Creatinine Clearance is less than 10 mL/minute: 25% of usual dose at usual interval.</value>
<value>Less than 1 month postnatal age 7 days or less AND body weight 2000 g or less.</value>
<value>Less than 1 month postnatal age 7 days or less AND body weight greater than 2000 g.</value>
<value>Postnatal age more than 7 days AND body weight 1200 g or less.</value>
<value>Postnatal age more than 7 days AND body weight 1200 to 2000 g.</value>
<value>Postnatal age more than 7 days AND body weight greater than 2000 g.</value>
<value>Therapy cycle is 28 days of treatment followed by 28 days off therapy. Bronchodilator should be administered prior to dose.</value>
</additionalnotes><population><value>ADULT</value>
<value>INFANT / CHILDREN</value>
<value>NEONATE / INFANT</value>
<value>ADULT / CHILDREN, aged 6 years and older.</value>
</population><indicationprn><value></value>
</indicationprn><backgroundinformation><value>http://intraweb01.albertahealthservices.ca/Pharmacy/AHS_FORMULARY/search_details.aspx?id=4473</value>
<value></value>
</backgroundinformation><prninformation><value></value>
</prninformation><ahsformularystatus><value>Formulary with Usage guidelines. Health Canada Special Access Programme.</value>
<value>Formulary with Restrictions.</value>
</ahsformularystatus><ahfsname><value>Antibacterials, Miscellaneous beta-Lactams</value>
</ahfsname><highalert><value></value>
</highalert><maximumprndose><value></value>
</maximumprndose></drug>